Caris Life Sciences Basel, Switzerland
David Spetzler, MS, MBA, PhD serves as Chief Scientific Officer and President of Caris Life Sciences, Inc. and served as its Senior Vice President. Spetzler joined the Caris Life Sciences scientific team in August 2009, where he leads the Research and Development division of Caris. His executive and scientific oversight of the R&D team is focused on the development of clinical assays to aid in the creation of precision medicine strategies for individual cancer patients, as well as noninvasive technologies to identify and predict early stage cancer. His work is focused on the development of the ADAPT Biotargeting System™, a groundbreaking and proprietary method of profiling macro-molecular complexes in their native form in a highly multiplexed format.